Effects of a Tailored Physical Activity Intervention on Cardiovascular Structure and Function in Individuals With Spinal Cord Injury.

BACKGROUND: Spinal cord injury (SCI) leads to a loss of descending motor and sympathetic control below the level of injury (LOI), which ultimately results in chronically altered cardiovascular function and remodeling. While supervised, laboratory-based exercise training can generate cardiovascular adaptations in people with SCI, it is unknown whether behavioral community-based interventions effectively generate such adaptations for individuals with SCI.
OBJECTIVE: Examine the effects of a tailored behavioral physical activity (PA) intervention on cardiac and vascular structure and function in individuals with SCI.
METHODS: In this randomized controlled trial, 32 participants with SCI (18-65 years, SCI >1 year) were assigned to PA (8-week behavioral intervention) or control (CON) groups. At baseline and postintervention, measures of resting left ventricular (LV) structure and function, carotid intima-media thickness and pulse-wave velocity were assessed with ultrasound and tonometry.
RESULTS: Twenty-eight participants completed the study (n = 14/group). Across the full study cohort there were no significant changes in indices of LV or vascular structure and function, despite notable improvements in peak power and oxygen uptake in the PA group. However, in a subanalysis for LOI, individuals in the PA group with LOIs below T6 had evidence of altered LV geometry (ie, increased LV internal diameter, reduced sphericity index and relative wall thickness; group × time P < 0.05 for all), which was not seen in individuals with higher LOIs at or above T6.
CONCLUSION: An 8-week behavioral PA intervention appears to promote adaptations in cardiac geometry more readily in individuals with lower level SCI than those with higher-level SCI.

Introduction

Individuals with spinal cord injury (SCI) have functional, contextual, and health condition-related barriers to physical activity (PA) participation. Given the large quantities of these barriers and their associated challenges, it is not surprising that people with SCI report some of the lowest PA levels compared with able-bodied individuals and other populations with chronic disease and disability. Recently, PA guidelines have been developed for the SCI population based on findings from supervised exercise trials in controlled laboratory settings. These guidelines recommend ≥20 minutes of moderate-to-vigorous aerobic activity twice weekly complimented with resistance exercise for fitness benefits, and ≥30 minutes of moderate-to-vigorous aerobic activity 3 times per week for cardiometabolic benefits. Behavioral interventions, or strategies that support self-management of PA, may be a pragmatic and effective way to address the low PA levels observed in the SCI population, and ultimately support those individuals toward achieving the recommended PA guidelines. Such interventions in SCI have shown cardiorespiratory and metabolic benefits[4,5]; however, to our knowledge, no trial has yet evaluated the effects of a community-based behavioral PA intervention on cardiac and vascular structure and function in the SCI population.

The combined loss of motor control and descending sympathetic control below the level of SCI results in chronically altered cardiovascular function and remodeling of the heart and vasculature[6,7] that are generally more pronounced with higher levels of injury (LOI).[8,9] These cardiovascular consequences have important clinical relevance as SCI has been associated with ~3- to 4-fold increased odds of cardiovascular disease. While the impacts of SCI on the vasculature are relatively well-established (eg, blood pressure dysregulation, arterial stiffening, and remodeling ), the cardiac responses to SCI have only recently gained increasing attention. In a meta-analysis of echocardiographic data, our group has identified that left ventricular (LV) volumes and structural dimensions are smaller in SCI compared with able-bodied individuals, in addition to reduced LV mass and altered ejection and filling function.

Exercise training is a potent stimulus for physiological cardiovascular adaptations. However, studies examining the effects of increased PA in people with SCI most often apply cross-sectional designs comparing highly trained individuals (ie, national- or Paralympic-level athletes[14-16]), who are not representative of the wider SCI population, with nonathletes. Among longitudinal and case-control studies to date, few have examined echocardiographic measures of cardiac structure and function following a PA intervention.[17-21] Findings are highly variable amongst those studies, and most have applied laboratory-based exercise modalities such as functional electrical stimulation (FES) exercise[17,20,22] or bodyweight supported treadmill training that are not widely available to individuals within their local communities.

Accordingly, the main aim of this study was to examine the effects of a tailored, community-based behavioral PA intervention (ProACTIVE SCI) on cardiovascular structure and function in individuals with SCI. While peak oxygen uptake and power output data from the ProACTIVE SCI trial are previously reported,[23,24] the current study’s key outcomes included LV end-diastolic volume (EDV), stroke volume (SV), and pulse-wave velocity (PWV). It was hypothesized that LV volumes would increase and PWV would decrease following the 8-week behavioral PA intervention. Next, given that high-level SCI impairs descending sympathetic input to the heart and vasculature, an exploratory subanalysis was performed to assess the influence of LOI on the cardiovascular responses to the PA intervention. Finally, we sought to elucidate predictors of cardiorespiratory fitness in individuals with SCI.

Methods

Study Participants and Ethical Approval

A total of 32 participants were recruited from the greater Vancouver, Canada area from May to July 2017. Ethical approval was granted by the University of British Columbia Clinical Research Ethics Board (H17-00559), and written informed consent was obtained from all participants. The study conformed to the Declaration of Helsinki.

Participants were included if they were living with chronic (>1 year) SCI, 18 to 65 years of age, cleared by a physician to exercise, and currently performing <150 minutes of moderate-to-vigorous PA/week (Canadian Physical Activity Guidelines for Aerobic Activity ). Participants were excluded if they had an active stage 3 or 4 pressure ulcer, trauma, or surgery <3 months prior to the study, lacked proficiency in English that would affect their ability to follow instructions, and/or had any unstable medical/psychiatric condition that might prevent them from completing the study.

Prior Publications From the ProACTIVE SCI Trial

Primary manuscripts for the ProACTIVE intervention detail its development and report changes in weekly PA participation, peak oxygen uptake (VO2peak) and peak power (POpeak).[23,24] This manuscript uniquely reports on resting cardiac and vascular measures, as well as changes in peak cardiorespiratory function (eg, peak oxygen pulse [O2pulsepeak], heart rate [HRpeak], and ventilation [VEpeak]) that are not previously reported from the ProACTIVE trial (Supplemental Table 2). VO2peak and POpeak data are included in the current article for the subgroup analysis based on LOI, and to assess the potential cardiac, vascular, and demographic predictors of cardiorespiratory fitness in individuals with SCI.

Study Design

Randomized Controlled Trial

Participants were initially matched by baseline self-reported leisure time PA levels and randomly assigned to either the physical activity (PA) intervention or control (CON) groups using a random numbers generator. Interventionists were not blinded to group assignment; however, all analyses of cardiovascular outcomes were performed blinded. The RCT followed the preregistered protocol at clinicaltrials.gov (identifier: NCT03111030). Individuals were informed verbally of their group assignment on completion of baseline measures.

Physical Activity Intervention

Detailed descriptions of the ProACTIVE SCI intervention and its co-development are provided elsewhere.[23,24] The intervention was delivered by a single researcher (JM), an American College of Sports Medicine–certified inclusive fitness trainer with >7 years of experience training individuals with SCI. A 1-hour introductory session included assessments of baseline PA levels, activity preferences, barriers, and accessibility to PA. Together, the researcher and participant set PA goals toward achieving or exceeding the SCI PA guidelines, which recommend strength training of all major, functioning muscle groups ≥2 d/wk, plus ≥30 minutes aerobic activity ≥3 d/wk for cardiometabolic benefits. Participants randomized to the PA intervention completed their introductory coaching session and 8 weekly PA coaching sessions (10-15 minutes each), while participants in the waitlist condition (CON) were scheduled to begin coaching sessions after their postintervention assessments for the study.

During each coaching session, the researcher and participant discussed PA progress and worked toward problem solving for issues related to education (eg, general PA information, self-regulatory strategies), referral (eg, peers, programs, organizations), or by revising their goals, PA program and/or action plan. Coaching sessions were delivered face-to-face at the research facility, over Skype, or when the former modes were unavailable, over the phone. PA was performed in the setting of their choosing (eg, home, gym, community center).

Assessments of Cardiovascular Outcomes and Peak Aerobic Fitness

Cardiovascular measures and peak exercise tests were performed at preintervention and repeated 9 weeks later at postintervention. Participants were instructed to take medications as normal, but refrain from exercise, caffeine, and alcohol on the day of testing, and avoid significant food or drink 4 hours prior to testing. During each testing session, participants were transferred to a flat medical bed and rested ≥10 minutes. Two participants who could not be transferred to the bed reclined their power wheelchairs to a near-supine position. Cardiac and vascular ultrasound and tonometry were sequentially performed, after which participants were transferred off the testing bed to complete a peak aerobic exercise test.

Specific Methodology

Participant Demographics and Medical Information

Demographic information including sex, age, completeness of injury, LOI, years postinjury, primary mode of mobility, highest level of education, ethnicity, and any current medications or medical complications were collected using an online form. When applicable, participant body mass was calculated using a wheelchair scale (PUA220A; Mettler) by subtracting chair mass from combined chair and body mass.

Transthoracic Echocardiography

All echocardiographic imaging and analyses were performed by a single, highly trained sonographer blinded to participant identifiers and condition. Images were acquired using a commercially available ultrasound system (Vivid 7, GE Healthcare) and 1.5- to 4-MHz phased-array transducer (M5S probe) and saved for offline analysis (EchoPAC v.113, GE Healthcare). The torso was positioned in a left-lateral orientation by placing a foam wedge under the right side-body. Two-dimensional B-mode and pulsed Doppler recordings were acquired at end-expiration for measures of LV structure and function in accordance with current guidelines, as described previously. Volumetric indices (ie, EDV, SV, end-systolic volume [ESV], ejection fraction [EF]) were measured using the modified Simpson’s biplane. LV length was averaged from measures in the apical 2- and 4-chambers at end-diastole. LV end-diastolic internal diameter (LVIDd), posterior wall thickness (PWT), and septal wall thickness (SWT) were measured in the parasternal long axis. Sphericity index, a ratio of the length-to-width geometry of the ventricle and an important determinant of LV function,[30,31] was calculated as LV end-diastolic length/LVIDd. Relative wall thickness, the ratio of the LV wall thickness relative to its chamber diameter, which is often altered with physiological remodeling, was calculated as 2·PWT/LVIDd. LV mass was estimated as 1.04·[(SWT + LVIDd + PWT) − LVIDd ]·0.8 + 0.6 g. Images for speckle tracking analysis were acquired at 70–90 frames/s. All echo-derived data were averaged across 3 cardiac cycles.

Speckle-Tracking Analysis

Analyses of LV mechanics (ie, rotation, twist, strain) were performed with speckle tracking software (EchoPAC v.113, GE Healthcare) as detailed elsewhere. Rotation and strain were measured across the entire myocardial region of interest. Data were time-aligned and transformed to 1200 points using cubic spline interpolation (2D Strain Analysis Tool), and peak values averaged across 3 cardiac cycles. Twist was calculated by subtracting time-aligned basal rotation from apical rotation. Tracking was inadequate for twist data in n = 5 individuals from PA and n = 2 from CON.

Vascular Ultrasound and Tonometry

Vascular imaging and tonometry were performed by a single experienced investigator. Common carotid artery (CCA) intima-media thickness (IMT) was assessed using 2-dimensional B-mode ultrasound (Vivid 7, GE Healthcare) and a 5- to 13-MHz linear-array transducer (12L probe). Images were captured in the anterolateral plane, 1 to 2 cm from the carotid bulb, across 5 cardiac cycles. Analyses were completed offline using commercial edge-detection software (EchoPAC v.113, GE Healthcare), and measures of distal wall IMT at end-diastole (R-wave) were averaged over 3 cardiac cycles. Mean CCA-IMT was calculated as the average of right- and left-sided measures. Data supporting the reliability of IMT measurements among individuals with SCI are described previously.

Measurements of carotid-femoral PWV were performed in accordance with current international guidelines. Handheld tonometry (SPT-301; Millar Instruments) was applied sequentially at the left femoral and carotid arteries for the acquisition of arterial pressure waveforms. Brachial blood pressure was captured from the left arm with an automated cuff (Dinamap Carescape V100; GE Healthcare), and HR was continually recorded from three-lead electrocardiogram (ML123, ADInstruments). PWV was calculated as (0.8 × D) ÷ ∆t, where D is the distance between carotid and femoral sites and ∆t is the pulse transit time. Arterial waveforms were bandpass filtered (2-30 Hz) and the minimum value of the filtered signal was used to identify the upstroke of the waveform. PWV was averaged across 20 consecutive cardiac cycles. Intraobserver test-retest reliability for PWV was ICC (intraclass correlation coefficient) = 0.923, similar to previous reports in SCI.

Peak Aerobic Exercise Test

Cardiorespiratory fitness was assessed during a graded exercise test on an electronically braked arm ergometer (Angio Rehab arm ergometer, Lode). Participants were instructed to maintain a cadence of ~50 rpm, and after an initial warm-up (0 W) power output was increased 10 W/min or 5 W/min for participants with paraplegia or tetraplegia, respectively, until volitional exhaustion (ie, unable to maintain ≥30 rpm ). Breath-by-breath gases were collected using a metabolic gas analyzer (Quark CPET, Cosmed) and HR was monitored using a Polar Electro H1 sensor (Polar). Values for VO2peak, O2pulsepeak, volume of exhaled carbon dioxide (VCO2peak), HRpeak, VEpeak, breathing frequency (fRpeak), and tidal volume (VTpeak) were selected using 30-second rolling averages. Ratings of perceived exertion were collected in the final 10 seconds of each stage (Borg 6-20 scale).

Statistical Analyses and Power Calculation

All data are reported as mean ± standard deviation. Participant characteristics were compared between groups using independent-samples t tests for continuous variables and Pearson’s chi-square for categorical data. Cardiac and vascular data were assessed using analysis of covariance (ANCOVA) with main effects for time and group, and baseline VO2peak (mL/kg/min) as covariate to account for the influence of aerobic fitness on cardiovascular measures. Cardiorespiratory data were assessed using a 2-way repeated-measures analysis of variance (ANOVA) with main effects for time (pre- vs postintervention period) and group (PA vs CON). Post hoc comparisons were performed using Tukey’s HSD (honest significant difference) test. A subanalysis for LOI was performed by splitting the study cohort into high (ie, at or above [≥] T6) and low LOI (ie, below [<] T6). The same ANCOVA analysis was performed for those LOI cohorts, and planned comparisons of baseline versus postintervention data were performed using Fisher’s LSD (least significant difference) method.

Linear mixed effects modelling was performed to elucidate predictive factors of VO2peak in individuals with SCI. Left ventricular EDV, SV, cardiac output (Q), LVIDd, LVlength, LVmass, IMT, and PWV, as well as age, sex, LOI, VEpeak, and HRpeak were assessed as fixed factors. Time was included as a repeated factor, and participant as a random factor. Fixed factors that did not significantly contribute to the model were excluded from further iterations. Significance was set a priori at α = .05. All statistical analyses were performed using SPSS Statistics (version 27.0, IBM Corp).

Power and Sample Size Calculations

This study reports cardiovascular outcomes from the ProACTIVE SCI RCT wherein leisure time PA was the primary outcome of interest. The sample size calculation for that study was based on a previous behavioral PA intervention for individuals with SCI. With a power of 0.80 and α = .05, n = 30 individuals were required to detect the large-sized effect reported in a comparable study (d = 0.96).

With regard to the primary cardiovascular outcomes of the current report, previous studies have reported altered EDV (+9 mL, SD = 9 mL) and PWV (−0.5 cm/s, SD = 0.3 cm/s) in individuals with SCI following PA interventions. With a power of 0.80 and α = .05, we required 14 individuals to detect these effects in the PA group. As such, we were sufficiently powered with n = 14 per group to detect significant alterations to our primary cardiovascular outcomes following the PA intervention.

Results

Participant Demographics

Twenty-eight participants completed the study (n = 14 per group). Two individuals had complete C4 injuries, which precluded them from completing a VO2peak test. Preintervention self-reported PA and accelerometer data are reported previously and were not different between PA and CON groups. There were no between-group differences in age, mass, proportions of male and female participants, or injury demographics (Table 1). Both groups had similar proportions of individuals with high LOI (ie, SCI ≥T6), traumatic SCI as well as neurological completeness of injury. Additional details related to injury characteristics are provided in Supplemental Table 1.

Table 1.

Participant Demographics and Injury Characteristics.

Demographic	Physical activity intervention (PA), n = 14	Control (CON), n = 14	P
Age, y, mean (SD)	45.8 (13.6)	45.6 (10.5)	.96
Body mass, kg, mean (SD)	74.1 (22.8)	77.7 (15.5)	.64
Sex, male/female, n	9/5	8/6	0.70
Characteristics of SCI
Time post-injury, y, mean (SD)	14.7 (13.9)	18.1 (10.9)	.47
SCI ≥T6 and AIS A, n (%)	7 (60)	6 (57)	.70
SCI ≥T6 and AIS B-D, n (%)	1 (36)	3 (43)	.28
SCI <T6, n (%)	6 (57)	5 (50)	.70
Traumatic SCI, n (%)	11 (79)	11 (79)	1.00
Primary mode of transportation, manual chair/power chair b , n	9/3	6/5	.52

Abbreviations: SCI, spinal cord injury; AIS A, American Spinal Injury Association Impairment Scale: a classification of A indicates a complete injury with no motor or sensory function below level of injury; a classification of B-D indicates an incomplete injury; ≥T6, at or above the sixth thoracic level.

Demographics are provided for participants in the physical activity intervention (PA) and control (CON) groups.

Other primary modes of transportation include no aid (n = 1) and scooter (n = 1) in the PA group, primarily walking (n = 2) and canes/walking poles (n = 1) in CON. See Supplemental Table 1 for detailed individual injury characteristics.

Resting Cardiovascular Structure and Function Pre- and Postintervention

There were no significant group, time, or interaction effects for LV volumes (ie, EDV, SV; Figure 1A and B), hemodynamics (ie, EF, Q; Figure 1C and D), or LV geometry (Figure 1E and F), despite significant improvements in cardiorespiratory fitness in the PA group (eg, VO2peak and POpeak; see Supplemental Table 2 for cardiorespiratory data). Among diastolic measures, only E′ (P = 0.008) and A′ (P = 0.025) were lower at postintervention in the PA group though not different from CON (Supplemental Table 3). There were no effects for LV twist mechanics, although untwisting velocity was elevated in the PA group compared with CON at baseline (P = 0.014) but not postintervention. Neither PWT nor CCA-IMT were different between groups or altered over time (Figure 1G and H). There were no significant effects for blood pressure (Supplemental Table 4).

Figure 1.

Resting cardiac and vascular measures at baseline (∇) and following the 8-week intervention period (∆). Bars represent means ± SD. Individual data are shown for participants in the physical activity (PA; green symbols) and control (CON; gray symbols). There were no main or interaction effects observed for echocardiographic measures of left ventricular end-diastolic volume (EDV; A), stroke volume (SV; B), ejection fraction (EF; C), cardiac output (Q; D), relative wall thickness (E), or sphericity index (F), despite significant improvements in cardiorespiratory fitness for the PA group (Supplemental Table 2). Likewise, vascular measures of pulse-wave velocity (PWV, G) and intima media thickness (IMT; H) were unchanged following the 8-week intervention period. n = 13 for both PA and CON. Additional cardiac and vascular data and statistics are found in Supplemental Tables 3 and 4.

Subanalysis for Level of Injury

No significant changes in cardiovascular structure or function were detected at the end of the intervention period in the high-LOI cohort; however, in low-LOI participants, significant interactions indicated that the PA group had increases to LVIDd (group × time P = .027) alongside reductions to sphericity index (group × time P = .049) and relative wall thickness (group × time P = .046; Figure 2A-C). There were otherwise no significant effects detected in the high- or low-LOI cohorts for measures of LV mechanics, Doppler velocities, IMT, PWV, or blood pressure. Both the high- and low-LOI cohorts had significant group × time interactions for relative VO2peak (≥T6 P = .002,

Figure 2.

Subanalysis for level of injury (LOI) of cardiorespiratory and left ventricular (LV) measures at baseline and postintervention. Cohorts with higher LOI (at or above [≥] T6) and lower LOI (below [<] T6) are shown in left- and right-hand panels, respectively. Bars represent means ± SD. Individual data are shown at baseline (∇) and postintervention period (∆) for participants in the physical activity (PA; green symbols) and control (CON; gray symbols) groups. In contrast to the high-LOI cohort, only the low-LOI cohort had significant group × time interactions for LV end-diastolic internal diameter (LVIDd; A), relative wall thickness (B), and sphericity index (C). Both cohorts, however, had significant improvements in peak oxygen uptake (VO2peak; D). *P < .05, **P < .01, #P ≤ .08 vs baseline.

Predictors of VO2peak

Using linear mixed modeling, cardiac and vascular variables of interest were initially included in the model (see Statistical Analyses and Power Calculation section for details). Due to significant multicollinearity, EDV, SV, and ESV were not input simultaneously. For predictors of absolute VO2peak, only EDV and EF significantly contributed to the model (F = 6.17, P = .004; Model 1, Table 2). Participant demographics (body mass, age, LOI, sex) were thereafter input to the model, whereby biological sex (F = 14.07, P < .001) and LOI (F = 10.44, P = .001) were the strongest predictors of VO2peak (F = 15.7, P < .001, Model 2), while EDV (P = .87) and EF (P = .11) became negligible. Inclusion of SV, Q, LVIDd, LVlength, LVmass, IMT or PWV did not improve the model fit. Finally, with the addition of peak cardiorespiratory measures, HRpeak significantly contributed to the model (F = 7.16, P = .011, Model 3) while VEpeak did not.

Table 2.

Cardiorespiratory and Demographic Predictors of VO2peak Derived From Linear Mixed Modeling for the Complete Study Cohort.a

	Final corrected model			Estimates of fixed effects
	Intercept	F	P	Variable	Coefficient	F	P
VO2peak (mL/min)
Model 1	1785	6.17	.004	EDV	8.3	7.55	.009
				EF	−23.7	4.04	.05
Model 2	1125	15.7	<0.001	Sex	M = 382.1F = 0	14.07	<.001
				LOI	H = −370.3L = 0	10.44	0.001
Model 3	460	8.54	<.001	Sex	M = 382.3F = 0	13.60	.001
				LOI	H = −262.4L = 0	6.84	.012
				HRpeak	4.6	7.16	.011
VO2peak (mL/kg/min)
Model 4	17.5	3.64	.062	LOI	H = −3.50L = 0	3.64	.062
Model 5	9.8	5.29	.009	LOI	H = −3.45L = 0	4.27	.045
				HRpeak	0.061	5.47	.024

Abbreviations: EDV, end-diastolic volume; EF, ejection fraction; LOI, level of injury; F: female; M:male; H, high-level injury (≥T6); L, low-level injury (

Models for absolute and relative VO2peak derived utilizing generalized linear mixed model, including “time” as a repeated effect and “participant” as a random effect. See Statistical Analyses and Power Calculation section for detailed modeling approach.

The same mixed modelling approach was applied for predictors of relative VO2peak (mL/kg/min). No resting cardiac or vascular variables were significant predictors; however, when demographics were included, LOI appeared to contribute to the model (F = 3.64, P = .062, Model 4). Finally, with the addition of peak cardiorespiratory variables, HRpeak and LOI together were predictive of relative VO2peak (F = 5.29, P = .009, Model 5).

Additional Cardiorespiratory Analyses

Further to the previously reported improvements in POpeak and VO2peak[23,24] (Supplemental Table 2 for statistics), additional cardiorespiratory analyses found significant group × time interactions for VEpeak (P = .004) and respiratory frequency (fRpeak, P = .0043), both of which tended to be augmented at postintervention in the PA group (P = 0.06 for both). VTpeak was otherwise unchanged at postintervention. HRpeak was unaltered, however O2pulsepeak was augmented in the PA group at post-intervention (Supplemental Table 2). There were no effects for respiratory exchange ratio, end-tidal PCO2, or ratings of perceived exertion, nor were there significant changes in body mass in the PA (−0.11 ± 4.9 kg; P = .94) or CON (+0.77 ± 3.5 kg; P = .44) groups.

Discussion

This study is the first to report on the effects of a community-based behavioral PA intervention on resting cardiac and vascular structure and function among people with SCI. In contrast to published interventions applying lab-based exercise modalities (eg, FES) and cross-sectional studies of highly trained athletes with SCI, the RCT employed community-based exercise in a sample representative of the wider SCI population. Following the 8-week ProACTIVE intervention period, resting cardiac and vascular measures were largely unaltered in the PA group, in contrast to our hypothesis. Interestingly, however, our subanalysis indicated that individuals with lower LOI (ie,

Cardiac and Vascular Adaptations in SCI: A Role for Level of SCI?

Although cardiac and vascular outcomes were not significantly altered in the PA group, the subanalysis of LOI provides evidence of LV remodeling in those with lower-level injuries. Specifically, significant interaction effects indicated alterations to LV geometry (ie, sphericity index and relative wall thickness) in those with injuries below T6, but not in individuals with SCI at or above T6. In the low LOI cohort, the lowered sphericity index and relative wall thickness resulted from a widening of LVIDd rather than from increased LV length or wall thickness. Such alterations to LV geometry are characteristic of eccentric remodeling and may have resulted from increased preload following the PA intervention. Cardiac preload is chronically lowered in individuals with SCI, and contributes to smaller LV dimensions and volumes in comparison with able-bodied individuals. Lowered LV preload in SCI is hypothesized to result, in part, from reductions to total blood volume associated with paralysis and a loss of descending sympathetic control below the LOI that impairs venous return and causes blood to pool in the capacitance vessels.[9,39] In the current study, those with lower LOI achieved greater exercise intensities (ie, VO2peak and POpeak) than those with higher LOI, which may have facilitated blood volume expansion, improved venous return and increased preload to ultimately alter LV geometry.

In contrast to the low LOI cohort, participants with high LOI did not have notable structural or functional alterations in the heart or arterial system, despite their improvements in aerobic fitness. These observations suggest that increased exercise intensities and/or muscular recruitment may be required to generate significant cardiovascular adaptations in high-level SCI. To date, only studies that have applied FES to the lower limbs have demonstrated altered cardiac function and remodeling in individuals with high-level SCI.[17,22] Likewise, most longitudinal studies reporting altered arterial structure, function, or PWV have applied FES in laboratory-based PA interventions.[41-43] Lower-body FES exercise may generate such cardiovascular adaptations via increased loading to the heart and vasculature (eg, preload, wall stress, shear), either by generating a lower-limb muscle pump with increased venous return, augmenting arterial blood flow to the paralyzed limbs, or facilitating blood volume expansion. Therefore, exercise modalities that augment cardiovascular loading either acutely during the exercise bout or chronically over the PA intervention may be necessary to alter cardiac or vascular outcomes in individuals with high-level SCI.

Although resting cardiac and vascular measures were largely unaltered in the PA group, we cannot preclude potential improvements to cardiovascular function during exercise. Similar to the current study, Milia et al reported improved VO2peak in an SCI cohort without detectable changes in resting cardiac measures following 12 months’ arm-ergometry training. However, they did observe enhanced cardiovascular responses (eg, HR, blood pressure, cardiac output) during metaboreflex activation. Davis et al also reported enhanced SV responses to isometric and submaximal exercise following 16 weeks’ arm-ergometer training, despite unaltered resting hemodynamics. It is therefore possible that the ProACTIVE intervention could have improved cardiac “reserve” or the cardiovascular responses to acute physiological stressors like exercise in the current study. Though we were unable to perform echocardiography during arm-crank exercise, the PA group had increased peak O2pulse at postintervention. Given that O2pulse is a validated and reliable measure of SV during exercise in able-bodied individuals and SCI, it is possible that the PA intervention facilitated improved cardiac responses to exercise in the current study. Future research should consider assessing the cardiovascular responses to physiological stressors, where possible, to better understand the potential benefits of PA interventions in SCI.

The improvements in VO2peak and exercise performance following the 8-week ProACTIVE intervention could otherwise be attributable, in part, to improvements in muscular strength or pulmonary function. Peripheral factors including skeletal muscle function are believed to represent a major limitation for VO2peak in nonathletic individuals with SCI,[40,47] and increased skeletal muscle strength has been linked to improved VO2peak in individuals with paraplegia and tetraplegia.[48,49] SCI can additionally paralyze the expiratory muscles and accessory inspiratory muscles, thereby limiting pressure generation with increasing ventilatory demand. Indeed, efforts to improve pulmonary function, including abdominal binding and short-term respiratory muscle training[51,52] have supported improvements to VO2peak and POpeak in highly trained tetraplegic individuals, even when PA levels are unchanged. In the current study, improved VEpeak in the PA group (P = 0.06) may have supported the increased aerobic performance to some degree. Ultimately, any long-term improvements to peripheral factors or pulmonary function could allow individuals with SCI to achieve greater exercise intensities and generate significant cardiovascular adaptations beyond the time period observed in the current study.

Regulators and Predictors of Cardiorespiratory Fitness in SCI

In an effort to elucidate the potential cardiac and vascular factors that regulate VO2peak in SCI, our mixed model analyses revealed resting LV EDV and EF as significant predictors of absolute VO2peak. This is a novel observation amongst the SCI literature to date, and indicates that larger LV volumes may support greater systolic “reserve” during aerobic exercise in SCI. While an inverse association between EF and VO2peak may appear at odds with the known relationship between systolic function and VO2peak, it is important to note that EF spanned a “healthy” and normal range (ie, EF = 51%-63%) in the current cohort. If participants with EFs lower than the healthy range were included, an inverse relationship would not be expected. When demographic and peak exercise data were included in the model, LOI, sex and HRpeak replaced EDV and EF as predictors of absolute VO2peak, presumably due to the influences of LOI and biological sex on LV volumes and ejection function.[9,53] As predictors of VO2peak, LOI was not surprising given that higher-level injuries are characterized by lower maximal oxygen uptake and HRpeak ; however, biological sex until now has not been considered in the context of SCI despite being a well-known independent predictor of maximal aerobic capacity in able-bodied males and females. These modeling data therefore highlight important links between LV volumes, LOI and biological sex, which ultimately play a role in determining aerobic exercise capacity among individuals with SCI.

Considerations and Future Directions

While it is possible that a longer intervention (>8 weeks) could allow for significant cardiovascular adaptations in the PA group, such a role for prolonged PA is not necessarily indicated by the current literature in SCI. Some studies comparing highly trained versus untrained individuals with SCI suggest an effect of long-term PA on cardiac and vascular measures,[16,55] though others often do not show differences between these groups.[14,15,40] Alternatively, the inability to activate the sympathetic nervous system and/or lower-limb motor function during exercise may preclude an effective stimulus for measurable cardiovascular effects, given the growing evidence that sympathetic activation may be necessary for cardiac and vascular adaptation.[56,57] To specifically address the important role of the autonomic system, future studies should consider the influence of “autonomic completeness” on the cardiac and vascular adaptations to PA interventions in individuals with SCI.

When mixed-model analysis was applied for relative VO2peak (mL/kg/min), none of the measured cardiac or vascular outcomes were significant predictors. Though the inclusion of allometrically-scaled cardiac and vascular data would have been more appropriate for modeling relative VO2peak, validated methods to calculate either body surface area or fat-free mass in individuals with SCI do not currently exist, precluding our ability to include scaled data in this model. It is critical that future work consider assessing approaches for allometric scaling (eg, “height” or body length) to allow for improved data analysis and interpretation among cardiovascular research in SCI.

Conclusions

In contrast to traditional laboratory-based, fully-supervised exercise training interventions, this study uniquely reports on the first RCT of a community-based behavioral PA intervention that assesses cardiac and vascular outcomes among individuals with SCI. The individualized ProACTIVE intervention appears to promote adaptations in cardiac geometry more readily in individuals with lower-level injuries than those with higher-level SCI.

Click here for additional data file.

Supplemental material, sj-pdf-1-nnr-10.1177_15459683211017504 for Effects of a Tailored Physical Activity Intervention on Cardiovascular Structure and Function in Individuals With Spinal Cord Injury by Alexandra M. Williams, Jasmin K. Ma, Kathleen A. Martin Ginis and Christopher R. West in Neurorehabilitation and Neural Repair